pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Opinion: Autonomous AI could surpass AI-assisted doctors on key tasks by 2030

Sep 9, 2026·read at STAT ↗Neutral

The piece, authored by Ezekiel J. Emanuel and Abe Baker-Butler, argues that autonomous artificial intelligence is likely to outpace both unaided physicians and those using AI assistance on five core cognitive medical tasks by the year 2030.

The authors compare the potential shift to historic advances such as Joseph Lister’s antiseptic technique, noting that transformative technologies often face initial resistance before widespread adoption.

While they acknowledge that AI will not replace doctors entirely, they suggest that autonomous systems will be far more capable than many skeptics anticipate, and they have discussed these ideas with AMA CEO John Whyte.

The article is presented as an opinion piece and does not present new data, but it highlights the growing conversation about the role of AI in clinical decision‑making.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Autonomous AI will beat AI-assisted physicians at some medical tasks by 2030”

read at STAT ↗
1,370 words · retrieved 33m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
University of Pennsylvania4LEADING2MIRA PHARMACEUTICALS, INC.
drugs
insulin
topics
ApprovalSchizophreniaType 2 DiabetesVaccines

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 18Amylyx’s bet on a GLP-1 blocker pays offBioPharma Dive
  • Jul 8Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsSTAT
  • Jun 15FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetesfda press